<DOC>
	<DOCNO>NCT01486966</DOCNO>
	<brief_summary>This trial conduct Asia . The aim trial compare efficacy safety insulin detemir plus insulin aspart NPH insulin plus human soluble insulin basal bolus regimen without metformin Chinese patient type 2 diabetes . The trial adopts group sequential design , analysis primary efficacy endpoint perform interim analysis , addition final formal analysis . The decision continue stop trial base result interim analysis .</brief_summary>
	<brief_title>Comparing Efficacy Safety Insulin Detemir Plus Insulin Aspart NPH Insulin Plus Human Soluble Insulin With Without Metformin Chinese Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Type 2 diabetes mellitus ( diagnose clinically ) 12 month longer Currently treat basal insulin daily premixed insulin twice daily least 3 month without OAD ( ) , total daily insulin dose le 1.4 IU ( U ) /kg ( If treat metformin , unchanged total daily dose least 1000 mg least 3 month ) Body Mass Index ( BMI ) equal 40 kg/m^2 HbA1c ( glycosylated haemoglobin A1c ) 7.0 % 10.0 % central laboratory analysis Plan admit optimising glycaemic control least 2 day prior randomisation Treatment thiazolidinediones ( TZD ) GlucagonLike Peptide1 ( GLP1 ) receptor agonist within last 3 month prior screen Anticipated change randomisation concomitant medication know interfere glucose metabolism , systemic corticosteroid , betablockers mono amine oxidase ( MAO ) inhibitor Previous participation trial ( participation define randomise . Rescreening screen failure allow within limit recruitment period . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>